Mylan-Mirtazapine 45 mg (Mirtazapine TABLET) 45 MG

Mirtazapine 45 mg tablets are an oral medication used to manage symptoms of depression. This antidepressant works by balancing certain natural substances in the brain, promoting emotional well-being.

Strength

45 MG

Pack Size

30/100

Manufacturer / TM Owner

MYLAN PHARMACEUTICALS ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mirtazapine 45 mg tablets are commonly prescribed for the treatment of major depressive disorder. This medication is designed to help alleviate symptoms such as persistent sadness, loss of interest, and changes in sleep or appetite. It is often used when other treatments have not been effective. Mirtazapine is also sometimes used to address sleep disturbances and anxiety associated with depression.

Side Effects

Mirtazapine 45 mg tablets may cause drowsiness, dizziness, increased appetite, and weight gain. Some users experience dry mouth, constipation, or blurred vision. These effects can vary and may not affect everyone in the same way.

Precautions & Warnings

Mirtazapine 45 mg tablets should be handled with care. It is important to follow the guidance of a healthcare provider regarding its use. This medication may not be suitable for individuals with certain medical conditions, such as liver or kidney disease. Always inform your healthcare provider about any other medications you are taking.

Avoid Interactions

Mirtazapine 45 mg tablets can interact with other medications, including those that cause drowsiness, such as alcohol and certain antidepressants. It is important to avoid alcohol while taking this medication. Always consult a healthcare provider before combining mirtazapine with other treatments.

Frequently Asked Questions

Mirtazapine is primarily used to treat major depressive disorder and may also help with sleep disturbances and anxiety.

Mirtazapine 45 mg tablets are typically taken orally, usually once daily, as directed by a healthcare provider.

Common side effects include drowsiness, dizziness, increased appetite, and weight gain.

Mirtazapine can interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Mirtazapine may not be suitable for individuals with certain medical conditions, such as liver or kidney disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.